A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

CHENNAI: After a nine-year-old boy from Thirvur in Tiruvallur district died due to Guillain-Barre Syndrome (GBS) — a rare ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.

During the pathogenesis of Parkinson’s disease (PD), α-synuclein pathology may originate in peripheral organs and spread to the CNS. Using human tissue samples and multiple approaches in mouse ...

Market Snapshot Stock-market investors are getting nervous about this bond-market move that’s only happened twice in over 40 years Only twice since the early 1980s has the 10-year yield jumped ...

New research has revealed that the nervous system circuitry that controls arm movement in octopuses is segmented, giving these extraordinary creatures precise control across all eight arms and ...

New research from the University of Chicago revealed that the nervous system circuitry that controls arm movement in octopuses is segmented, giving these extraordinary creatures precise control ...